Clinical Trial Update: Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a soluble fiber blend plus medium-chain triglycerides on body composition and cardiometabolic risk factors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Medium Chain Triglycerides (Medium-chain triglycerides)
• Soluble Fibre Blend

Snippet

Sponsor: Canadian Center for Functional Medicine | Conditions: People Who Are Overweight or Obesity | Phase 2 | Status: COMPLETED